Brian Nowosielski

From supporting MTM services to reaching unhoused populations, the 340B program is a powerhouse for patient care, access, and affordability.

This month’s event will explore policy, people, and profitability, and how pharmacy businesses can transform these factors toward actionable solutions.

In this episode, host Taylor Watterson, PharmD, PhD, provides a deeper look into workplace fatigue and the metrics used to calculate and facilitate it.

In part 2, Miller further breaks down the fragmentation of menopause care within today’s health care system and how pharmacists are uniquely positioned to fill in long-standing care gaps.

Across rural US community pharmacies, researchers explore the common barriers and facilitators to pneumococcal vaccine uptake.

Two separate bills were marked up in House committees last week and were officially advanced to potentially move additional PBM reform into law.

Lisa Miller, PharmD, MSCP, discusses fragmentation in US menopause care and the role pharmacists can play in improving collaboration.

Exploring pneumococcal vaccination rates among eligible adult patients, researchers conducted a quality improvement initiative at a clinic in Illinois.

Researchers hope to inform national strategies on pharmacists’ potential place in asthma management.

The proposed bill would force pharmacy benefit managers to act on the interests of pharmacies rather than their own companies.

From PBM reform and AI to burnout and closures, Tom DePietro, PharmD, addresses the current state of independent pharmacy.

Results of Eli Lilly’s investigational triple agonist were reported in the TRIUMPH-1 Phase 3 clinical trial.

Although currently contained outside of the US, the Bundibugyo strain of the virus reached an American worker in the Democratic Republic of Congo.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Sarah Chew, MPH, to discuss the pharmacist’s role in advancing women’s health research.

In part 2, Tom DePietro, PharmD, explores emerging topics of interest within community pharmacy, including AI, PBMs, and the industry’s evolving nature.

With Commissioner Makary resigning just days prior, this marks the second and third major change in the federal agency’s leadership this month.

Jeffery Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases, provided his expert perspectives on the ongoing hantavirus outbreak.

Between clinical initiatives, educational strategies, and regulatory frameworks, researchers explore PGx services integration.

From PBM reform designed to benefit pharmacies to closures impacting the greater public health sector, Tom DePietro, PharmD, discusses current developments in community pharmacy.

Despite a myriad of data and news releases about the growing prominence of AI in pharmacy practice, several knowledge and acceptance gaps persist.

An exploration of key takeaways from the first 4 episodes of Scripted for Her, featuring host Natalie DiPietro Mager, PharmD, PhD, and experts from a variety of clinical backgrounds in women’s health.

As diabetes rises to be one of the most prominent chronic diseases globally, pharmacists have reached out as key resources for preventing and managing its complications.

As health officials respond to ongoing concerns, Nathan Ott, PharmD, joined to discuss key hantavirus facts that pharmacists can relay to their communities.

Among both childhood and adult populations, researchers assess the quality of life across a large cohort of patients reporting pneumococcal disease cases.

In part 2, Staci-Marie Norman, PharmD, CDCES, FAPhA, and Susan Cornell, PharmD, CDCES, FAPhA, FADCES, discuss the pharmacist’s ability to meander a booming medication class in GLP-1s.

Despite common trends in the specialty drug market persisting, a new pharmacy landscape must come together to address rising issues.

Preventing pneumococcal disease remains a cornerstone of public health, yet the strategy for protection is increasingly individualized and complex.

This episode explores the differences between behavior that is caught rather than taught, explaining how leadership can be a learned skill if properly approached.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, and Staci-Marie Norman, PharmD, CDCES, FAPhA, discuss current trends regarding CGM use and access behind the pharmacy counter.

Researchers explore invasive pneumococcal disease epidemiology after the introduction of multiple pneumococcal conjugate vaccines.